BI
ATXS

BVF Inc’s Astria Therapeutics ATXS Stock Holding History

BVF Inc’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,750
Closed -$2.75M – 29
2015
Q2 		$2.75M Buy
+3,750
New +$2.83M 0.48% 23

Other funds holding ATXS

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc's ATXS Position: Q3 2015 in Review

BVF Inc sold out of Astria Therapeutics (ATXS) in Q3 2015, closing a stake of 3,750 shares — an estimated $2.75M sold.

BVF Inc first reported a position in ATXS in Q2 2015 and held it in 1 quarter. The position peaked at $2.75M in Q2 2015. 35 funds tracked by Wall St. Rank hold ATXS as of Q3 2015.

  • BVF Inc reported no remaining Astria Therapeutics position as of Q3 2015 after selling out during the quarter.
  • BVF Inc sold 3,750 Astria Therapeutics shares in Q3 2015, an estimated $2.75M.
  • BVF Inc first reported a position in Astria Therapeutics in Q2 2015 and held it in 1 quarter.
  • BVF Inc's Astria Therapeutics position peaked at $2.75M in Q2 2015.
  • 35 funds tracked by Wall St. Rank held Astria Therapeutics as of Q3 2015.

Based on BVF Inc's 13F filing for Q3 2015, filed 16 Nov 2015.